Forbes J M & CO LLP Abb Vie Inc. Transaction History

Forbes J M & CO LLP

$1 Billion
Q3 2024

A detailed history of Forbes J M & CO LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, Forbes J M & CO LLP holds 14,345 shares of ABBV stock, worth $2.58 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

14,345

Previous 14,345 -0.0%

Holding current value

$2.58 Million

Previous $2.46 Million 15.12%

% of portfolio

0.28%

Previous 0.26%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$154.79 - $180.76 $10,990 - $12,833	71 Added 0.5%	14,345 $2.46 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $10,044 - $11,312	-73 Reduced 0.51%	14,274 $2.21 Million
Q3 2023 Nov 02, 2023	BUY	$133.59 - $154.65 $40,077 - $46,395	300 Added 2.14%	14,347 $2.14 Million
Q2 2023 Aug 03, 2023	BUY	$132.51 - $164.9 $947,313 - $1.18 Million	7,149 Added 103.64%	14,047 $1.89 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $184,522 - $212,505	-1,276 Reduced 15.61%	6,898 $1.1 Million
Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $18,395 - $22,060	133 Added 1.65%	8,174 $1.32 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $15,147 - $19,166	-141 Reduced 1.72%	8,041 $1.09 Million
Q3 2021 Nov 05, 2021	SELL	$106.4 - $120.78 $36,708 - $41,669	-345 Reduced 4.05%	8,182 $883,000
Q4 2020 Feb 11, 2021	BUY	$80.49 - $108.67 $32,195 - $43,468	400 Added 4.92%	8,527 $914,000
Q3 2020 Nov 13, 2020	BUY	$85.91 - $100.83 $170,960 - $200,651	1,990 Added 32.43%	8,127 $715,000
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $3,547 - $5,378	-55 Reduced 0.89%	6,137 $468,000
Q4 2019 Feb 07, 2020	SELL	$72.13 - $90.25 $9,376 - $11,732	-130 Reduced 2.06%	6,192 $548,000
Q2 2019 Aug 02, 2019	SELL	$65.7 - $83.98 $4,270 - $5,458	-65 Reduced 1.02%	6,322 $460,000
Q1 2019 May 07, 2019	SELL	$77.14 - $90.79 $29,158 - $34,318	-378 Reduced 5.59%	6,387 $515,000
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $8.15 Million - $9.06 Million	-91,619 Reduced 93.12%	6,765 $640,000
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $13,377 - $15,828	149 Added 0.15%	98,384 $9.12 Million
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $98,450 - $131,834	1,070 Added 1.1%	98,235 $9.3 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $182,523 - $200,151	2,038 Added 2.14%	97,165 $9.4 Million
Q3 2017 Nov 13, 2017	SELL	$69.85 - $89.22 $79,698 - $101,800	-1,141 Reduced 1.19%	95,127 $8.45 Million
Q2 2017 Aug 10, 2017	BUY	N/A	96,268	96,268 $6.98 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forbes J M & CO LLP, based on Form 13F filings with the SEC.

News

Stay updated on Forbes J M & CO LLP with notifications on news.

Account